Radiopharmaceuticals Startup Secures $175M Funding

Radiopharmaceuticals Startup Secures $175 Million Funding

Aktis Oncology, a biotech startup based in Boston, has garnered significant attention in the healthcare investment sector by successfully raising $175 million. This funding round was supported by major investors, including RA Capital, RTW Investments, and Janus Henderson Investors. The startup is at the forefront of developing radiopharmaceutical treatments aimed at delivering targeted doses of radiation to specific tissues, primarily for cancer therapy.